In the latest edition of Deep Dive: Market Access II, Stefan Bosbach from phamax scrutinises the situation for people with rare bleeding disorders, including the challenges in recordin
Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho
